PEDIATRICS Vol. 108 No. 1 July 2001, pp. 54-60
Received Sep 5, 2000; accepted Nov 1, 2000.
,
, and
From the * New York State Department of Health, Albany, New
York; Objective. To describe epidemiologic
features of intussusception and rotavirus diarrhea in New York, to
examine the baseline incidence and trends over time, and to ascertain
whether an excess of cases occurred in the 9 months of vaccination with
the newly licensed rotavirus vaccine.
Methods. Hospital discharge data from 1989 through 1998 were reviewed for children (<1 year old) whose primary or secondary
diagnosis was coded as intussusception or rotavirus diarrhea.
Characteristics of patients admitted for intussusception and rotavirus
diarrhea were compared, and trends over time were examined. For a
subset of patients, medical records and vaccine histories for
intussusception hospitalizations from October 1998 through June 1999 were analyzed. The number of intussusception cases attributable to
rotavirus vaccine was calculated based on the penetration of the
vaccine (21%) and a range of excess risks of intussusception among
vaccinated children as estimated by the National Immunization Program
(NIP).
Results. From 1989 through 1998, 1450 intussusception-associated hospitalizations were reported in children
<1 year old (average annual incidence 5.4/10 000). Among these
children, 47% were treated medically and 53% had surgery, with 9%
needing surgical resection. The incidence of intussusception declined
over time from 6.1 per 10 000 in 1989 to 3.9 per 10 000 in 1998. Intussusception hospitalizations occurred throughout the year, whereas
rotavirus-associated hospitalizations peaked from February to April. Of
20 patients with intussusception whose hospitalization charts were
reviewed, 5 had received rotavirus vaccine. All 5 were hospitalized
after their first dose of vaccine, were admitted before 7 months of
age, were white, and had private insurance. A total of 81 cases
of intussusception occurred during the 9-month period of rotavirus
vaccination, compared with 78 during the same period in the
prevaccination year. The number of excess intussusception cases
observed (n = 3) was lower than expected using the
NIP estimate of excess risk (1.8) among rotavirus vaccinated children
(n = 12) but not significantly different from the
risks identified in the NIP cohort studies (1 in 12 000).
Conclusion. Our data suggest that in New York the rate of
intussusception has declined, and approximately 1 child in 2600 develops intussusception before 1 year of age. The different
seasonality between intussusception and rotavirus-related
hospitalizations suggests that if any causal association exists, it
must be small. Unlike other studies, analysis of New York hospitalized
discharge data failed to show an appreciable increase in the incidence
of intussusception after introduction of the rotavirus
vaccine.
Department of Epidemiology, School of Public Health, State
University at Albany, New York; § Epidemic Intelligence Service (State
Branch), Centers for Disease Control and Prevention, Atlanta, Georgia;
and
Viral Gastroenteritis Section, Division of Viral and Rickettsial
Diseases, National Center for Infectious Diseases, Centers for Disease
Control and Prevention, Atlanta, Georgia.
This article has been cited by other articles:
![]() |
J. E. Tate, L. Simonsen, C. Viboud, C. Steiner, M. M. Patel, A. T. Curns, and U. D. Parashar Trends in Intussusception Hospitalizations Among US Infants, 1993-2004: Implications for Monitoring the Safety of the New Rotavirus Vaccination Program Pediatrics, May 1, 2008; 121(5): e1125 - e1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Buettcher, G. Baer, J. Bonhoeffer, U. B. Schaad, and U. Heininger Three-Year Surveillance of Intussusception in Children in Switzerland Pediatrics, September 1, 2007; 120(3): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Warfield, S. E. Blutt, S. E. Crawford, G. Kang, and M. E. Conner Rotavirus Infection Enhances Lipopolysaccharide-Induced Intussusception in a Mouse Model J. Virol., December 15, 2006; 80(24): 12377 - 12386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Tai, A. T. Curns, U. D. Parashar, J. S. Bresee, and R. I. Glass Rotavirus Vaccination and Intussusception: Can We Decrease Temporally Associated Background Cases of Intussusception by Restricting the Vaccination Schedule? Pediatrics, August 1, 2006; 118(2): e258 - e264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lynch, W.-J. Shieh, J. S. Bresee, K. M. Tatti, J. R. Gentsch, T. Jones, B. Jiang, E. Hummelman, C. M. Zimmerman, S. R. Zaki, et al. Intussusception After Administration of the Rhesus Tetravalent Rotavirus Vaccine (Rotashield): The Search for a Pathogenic Mechanism Pediatrics, May 1, 2006; 117(5): e827 - e832. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Lee, R. Lee, and L. G. Yamamoto Intussusception Incidence Relative to Rotavirus Vaccine Use in Honolulu Clinical Pediatrics, November 1, 2005; 44(9): 791 - 795. [Abstract] [PDF] |
||||
![]() |
Y E Chen, S Beasley, K Grimwood, and and the New Zealand Rotavirus Study Group Intussusception and rotavirus associated hospitalisation in New Zealand Arch. Dis. Child., October 1, 2005; 90(10): 1077 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kolsen Fischer, K. Bihrmann, M. Perch, A. Koch, J. Wohlfahrt, M. Kare, and M. Melbye Intussusception in Early Childhood: A Cohort Study of 1.7 Million Children Pediatrics, September 1, 2004; 114(3): 782 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Peter and M. G. Myers Intussusception, Rotavirus, and Oral Vaccines: Summary of a Workshop Pediatrics, December 1, 2002; 110(6): e67 - 67. [Abstract] [Full Text] [PDF] |
||||